Results 31 to 40 of about 1,427 (143)

Long noncoding RNA FTX promotes epithelial-mesenchymal transition of epithelial ovarian cancer through modulating miR-7515/TPD52 and activating Met/Akt/mTOR [PDF]

open access: yes, 2023
Overexpressed long noncoding RNA FTX is associated with low survival rate of epithelial ovarian cancer (EOC) patients, and enhances tumor infiltration. Thus, we aim to illuminate the undefined underlying mechanisms.
Xia, Fei   +7 more
core   +1 more source

TPD52 (tumor protein D52) [PDF]

open access: yes, 2011
Review on TPD52 (tumor protein D52), with data on DNA, on the protein encoded, and where the gene is ...
Byrne, J   +3 more
core   +1 more source

Star-PAP regulates tumor protein D52 through modulating miR-449a/34a in breast cancer

open access: yesBiology Open, 2019
Tumor protein D52 (TPD52) is an oncogene amplified and overexpressed in various cancers. Tumor-suppressive microRNA-449a and microRNA-34a (miR-449a/34a) were recently reported to inhibit breast cancer cell migration and invasion via targeting TPD52 ...
Aizhu Duan   +5 more
doaj   +1 more source

Figure S3 from Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study

open access: yes, 2022
Fig S3. A) Density plot representing the distribution of the percentage of positive cell for tumors in the BH cohort. As described in the manuscript text, three broad categories of tumors were identified: TPD52 negative (no positive cells, 54.9% of ...
Olga Zheludkova (10095056)   +18 more
core   +1 more source

Tumor protein D52 (TPD52): A novel B-cell/plasma cell molecule with unique expression pattern and Ca2+-dependent association with Annexin VI. [PDF]

open access: yes, 2005
We generated a murine monoclonal antibody (B28p) detecting an antigenic determinant shared by the immunoglobulin superfamily receptor translocationassociated 1 (IRTA1) receptor (the immunogen used to raise B28p) and an unrelated 28-kDa protein that
Carbone A.   +22 more
core   +2 more sources

GLUTAMINE DEPRIVATION EFFECT ON DEK, TPD52, BRCA1, ADGRE5, LIF, GNPDA1, AND COL6A1 GENE EXPRESSIONS IN IRE1 KNOCKDOWN U87 GLIOMA CELLS [PDF]

open access: yesBiotechnologia Acta, 2017
To study effect of glutamine deprivation on the expression of genes encoding the key proliferation associated factors on a relation to inhibition of inositol requiring enzyme-1 IRE1 in U87 glioma cells was the aim of the research.
A. P. Kharkova   +6 more
doaj   +1 more source

Predicting 3D Structure, Cross Talks, and Prognostic Significance of KLF9 in Cervical Cancer

open access: yesFrontiers in Oncology, 2022
Our study aimed to identify the new blood-based biomarkers for the diagnosis and prognosis of cervical cancer. Moreover, the three-dimensional (3D) structure of Kruppel-like factor 9 (KLF9) was also determined in order to better understand its function ...
Sadia Safi   +11 more
doaj   +1 more source

Additional file 3 of Anti-osteosarcoma effect of antiserum against cross antigen TPD52 between osteosarcoma and Trichinella spiralis

open access: yes, 2021
Additional file 3: Table S3. Anti-TPD52 antiserum titre detection (OD450)
Hong-Bo Zhang (1351680)   +10 more
core   +1 more source

Expression of tumor growth related genes in IRE1 knockdown U87 glioma cells: effect of hypoxia [PDF]

open access: yesThe Ukrainian Biochemical Journal, 2017
We have studied the effect of IRE1 signaling enzyme knockdown as well as hypoxia on the expression of genes encoding the important tumor growth related proteins (BRCA1, DEK, BCL2L1, COL6A1, TPD52, HOMER3, and GNPDA1) in U87 glioma cells.
O. H. Minchenko   +5 more
doaj   +1 more source

Figure S4 from Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study

open access: yes, 2022
Fig S4. Overall survival analysis by Kaplan Meier plotting of patients with Group 3/4 medulloblastoma (BH cohort), after stratification based on therapeutic approach and TPD52 IHC. Children in A-B were treated with chemotherapy-only protocols.
Olga Zheludkova (10095056)   +18 more
core   +1 more source

Home - About - Disclaimer - Privacy